Wilson Therapeutics ^Companies

Wilson Therapeutics is a biopharmaceutical company based in Stockholm, Sweden. They focus on developing novel therapies for rare diseases, with a particular emphasis on Wilson Disease. Their lead product, Decuprate®, is currently being evaluated in a Phase II clinical study for Wilson Disease patients. Wilson Therapeutics aims to address unmet medical needs and improve the lives of patients with rare diseases through their innovative therapies.